Beijing SL Pharmaceutical Co (SZSE:002038) GF Score : 54/100 (As of Apr. 25, 2025)

View and export this data going back to 2004. Start your Free Trial

What is Beijing SL Pharmaceutical Co GF Score?

Beijing SL Pharmaceutical Co has the GF Score of 54, which implies that the company might have Poor future performance potential.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 9/10
2. Profitability Rank : 6/10
3. Growth Rank : 3/10
4. GF Value Rank : 3/10
5. Momentum Rank : 1/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Beijing SL Pharmaceutical Co might have Poor future performance potential.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Competitive Comparison of Beijing SL Pharmaceutical Co's GF Score

For the Drug Manufacturers - Specialty & Generic subindustry, Beijing SL Pharmaceutical Co's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beijing SL Pharmaceutical Co's GF Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beijing SL Pharmaceutical Co's GF Score distribution charts can be found below:

* The bar in red indicates where Beijing SL Pharmaceutical Co's GF Score falls into.

Save Embed

;

Save Embed

;

Beijing SL Pharmaceutical Co (SZSE:002038) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score	Performance Potential and All-in-One Screener Examples ⁽¹⁾
91 - 100	Highest outperformance potential
81 - 90	Good outperformance potential
71 - 80	Likely to have average performance
51 - 70	Poor future performance potential
0 - 50	Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Beijing SL Pharmaceutical Co GF Score Related Terms

Thank you for viewing the detailed overview of Beijing SL Pharmaceutical Co's GF Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing SL Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing SL Pharmaceutical Co Ltd (SZSE:002038) » Definitions » GF Score

Traded in Other Exchanges

N/A

Address

No.69 Fu shi Road, No.1 Building, Bitongyuan, Haidian district, Beijing, CHN, 100049

Website

http://www.slpharm.com.cn

Beijing SL Pharmaceutical Co Ltd is a Chinese biotechnology-pharmaceutical company. It is principally focused on developing and marketing gene engineering drugs. The product portfolio of the company includes drugs for Oncology, Hepatopathy and Senile disease. Its products include Filgrastim, Asparaginase, Dasartinib, Enoxaparin, Naftopidil, Ademetionine, Lenalidomide, and others.

Executives

Liang Shu Jie	Secretary, Director
Xu Ming Bo	Directors, executives
Yang Zhong Fan	Supervisors
Chen Yu Lin	Director
Qi Yan Ming	Supervisors
Xi Wen Ying	Executives
Wu Yan Zhuo	Executives
Wang Wen Xin	Director
Li Ya Jun	Executives
Zhao Xia	Securities Affairs Representative
Zhang Chun Lei	Supervisors
Wang Yong Bo	Directors, executives
Lu An Jing	Supervisors
Wei Su Yan	Director

Beijing SL Pharmaceutical Co Headlines

No Headlines